“Swiss pharma giant Roche agrees $7.1 billion deal to buy Telavant Holdings”
October 23, 2023
“Swiss health care company Roche on Monday announced it would acquire Telavant Holdings in a $7.1 billion transaction.
Telavant produces drugs for people suffering from inflammatory and fibrotic diseases and is in the process of developing a “promising new therapy” for patients with Crohn’s disease, Roche said in a press release. The terms of the acquisition include a near-term milestone payment of $150 million…”
https://www.cnbc.com/2023/10/23/roche-agrees-7point1-billion-deal-to-buy-telavant-holdings.html